SARAJEVO (Bosnia and Herzegovina), December 30 (SeeNews) – Luxembourg-based Haden is offering again for sale its remaining stake in Bosnian drug maker Bosnalijek [SAJ:BSNLR] at an extraordinary auction on January 15, the Sarajevo Stock Exchange (SASE) said on Monday.
Haden is selling 1,441,286 Bosnalijek shares at 18.85 marka ($10.7/9.6 euro) apiece, SASE said in a statement.
You can subscribe to our M&A newsletter here
According to SASE data, Bosnalijek's share capital is divided into 9.037 million shares of 10 marka in par value each, which puts the size of the stake offered for sale at 15.95%.
The last auction for the sale of Haden's stake held on the SASE on December 26 failed to attract any buyers. The ask price was also set at 18.85 marka per share.
Earlier this month, Haden sold part of its holdings in Bosnalijek representing some 10% of the company's share capital, for 17 million marka at an auction on the SASE, with 903,769 Bosnalijek shares changing hands at 18.85 marka.
Following the transaction, Raiffeisen Bank Bosnia and Herzegovina's stake in Bosnalijek rose to 11.34% from 1.34%, while Haden's stake shrank to 15.95% from 25.95%, according to December 27 bourse data.
Thus, KBC Euro Credit Capital became the largest single shareholder in Bosnalijek with ownership of 23.67%, followed by Haden, Raiffeisen Bank, and Libya's Economic and Social Development Fund with 7.60%, bourse data showed.
Bosnalijek shares closed 2.67% higher at 18.52 marka on the SASE on Monday.
(1 euro = 1.95583 marka)